Scientists at the University at Buffalo (UB) in New York have received a five-year $3.8-million grant to develop methods to…
Articles by Marisa Wexler, MS
Parents of children with late-onset Pompe disease (LOPD) that is identified via newborn screening report not receiving enough information,…
A report describes the unusual case of a man with late-onset Pompe disease (LOPD) that manifested with abnormalities in…
ABX1100, an experimental substrate reduction therapy that Aro Biotherapeutics is developing for Pompe disease, has been granted an…
The European Commission has approved the next-generation enzyme replacement therapy Nexviadyme (avalglucosidase alfa) to treat both late-onset and infantile-onset…
Spark Therapeutics is offering new research grants to scientists working on a number of topics related to Pompe…
Adding L-alanine supplements to standard enzyme replacement therapy (ERT) for a young girl with Pompe disease led to…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
An intervention involving whole body vibration therapy showed promise for improving movement ability and muscle composition in a small study…
A program of supervised resistance exercise can improve muscle function — including in muscles needed to breathe — for adults…